NP / RN / PA Aesthetic Practice FAQ
Should my medspa accept insurance or be cash-pay?
Aesthetic medspas are typically cash-pay because cosmetic neuromodulators and dermal fillers are not covered by Medicare or commercial insurance. Therapeutic neuromodulator indications (chronic migraine, hyperhidrosis, masseter for TMJ) can sometimes be billed but the administrative overhead rarely justifies it for a pure aesthetic practice.
Almost all NP-owned medspas operate cash-pay. The reasoning is structural, not preference.
What insurance doesn't cover: - Cosmetic neuromodulator (Botox, Dysport, Xeomin, Daxxify for aesthetic indications) - Dermal fillers (Restylane, Juvederm, RHA, Belotero, Versa, Sculptra) - Aesthetic laser treatments - Microneedling, chemical peels, dermaplaning - Body contouring (CoolSculpting, EmSculpt, etc.) - PRP and exosome treatments - Cosmetic-indication weight-loss services (most contexts)
What insurance can cover in some contexts (with significant administrative friction): - Chronic migraine neuromodulator (Botox) for patients with diagnosis - Hyperhidrosis (excessive sweating) neuromodulator - Cervical dystonia, blepharospasm, and other medical neuromodulator indications - Masseter hypertrophy / bruxism (state and carrier-dependent) - Some medical-indication weight-loss services (GLP-1 prescribing for diagnosed obesity, type 2 diabetes)
The decision framework most NP-owned medspas use:
Pure aesthetic practice — cash-pay only. No insurance billing infrastructure. Patient pays at time of service. Credit card processor (Square, Stripe, or healthcare-specific). No claims, no AR cycle, no denial management.
Aesthetic + medical-indication weight loss (GLP-1) — typically cash-pay even for weight-loss, because: - Many insurance plans don't cover GLP-1 for non-diabetic obesity - Cash-pay GLP-1 pricing is often competitive with insurance copays after deductible - Administrative overhead of insurance billing erodes margin significantly
Aesthetic + medical wellness (hormone, IV therapy, peptides) — almost always cash-pay.
The administrative cost of insurance billing: - Credentialing with insurance carriers takes 60–120 days per carrier - Claim submission, follow-up, and denial appeals require either a billing service ($300–$1,000+/month) or trained staff - Average commercial reimbursement on aesthetic-adjacent therapeutic codes is often less than your cash-pay rate - Patient responsibility (copay/coinsurance) collection adds friction
When insurance does make sense: - Established NP practice with existing insurance infrastructure (e.g., NP transitioning from a primary-care role into aesthetics) - Multi-clinician practice where one clinician serves insurance-bearing patients (medical neuromodulator indications, migraine) and others serve cash-pay aesthetics - Aesthetic practice in a market where the demographic actively asks about insurance coverage and won't proceed without trying
The vast majority of NP-owned aesthetic medspas operate cash-pay from Day 1 and stay there. It simplifies operations, reduces administrative cost, and aligns with the elective nature of aesthetic services.
My Practice Academy teaches the cash-pay practice as the default model. The free assessment at /find-your-starting-point returns model selection guidance specific to your goals.